BRUNELLI, NICOLETTA
 Distribuzione geografica
Continente #
AS - Asia 1.715
EU - Europa 75
NA - Nord America 53
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Totale 1.848
Nazione #
SG - Singapore 1.666
US - Stati Uniti d'America 50
CN - Cina 29
IT - Italia 18
DE - Germania 13
HK - Hong Kong 13
AT - Austria 10
GB - Regno Unito 10
IN - India 5
NL - Olanda 5
FI - Finlandia 4
EE - Estonia 3
FR - Francia 3
UA - Ucraina 3
AU - Australia 2
HR - Croazia 2
MX - Messico 2
PT - Portogallo 2
BO - Bolivia 1
BR - Brasile 1
CA - Canada 1
CD - Congo 1
ID - Indonesia 1
PL - Polonia 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 1.848
Città #
Singapore 31
Hefei 19
Ashburn 11
Hong Kong 11
Rome 10
Boardman 8
Nuremberg 7
Edinburgh 5
Shanghai 4
Amsterdam 3
Bologna 3
Chennai 3
Seattle 3
Glasgow 2
Helsinki 2
London 2
Mexico City 2
Porto 2
Pune 2
Santa Fe 2
Trogir 2
Vienna 2
Atina 1
Beijing 1
Boca Raton 1
Brisbane 1
Central 1
Council Bluffs 1
Guangzhou 1
Kinshasa 1
Los Angeles 1
Melbourne 1
Messina 1
Miami 1
Montreal 1
Moscow 1
Munich 1
Nanjing 1
North Bergen 1
Nottingham 1
Pittsburgh 1
Raleigh 1
Redenção 1
San Francisco 1
Santa Clara 1
Secaucus 1
Shenzhen 1
Sucre 1
Tampere 1
Turku 1
Warsaw 1
Weilheim 1
Totale 166
Nome #
Assessment of cerebral hemodynamics in patients with acute stroke and transient ischemic attack with different etiopathogenesis 180
Psychopathological variables in chronic migraine patients with different therapeutic approach: psychological profile differences and impact on therapeutic efficacy in real life 174
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study 164
Stroke territory and atherosclerosis in ischemic stroke patients with a history of migraine with aura 157
Right-to-Left Shunt and the Clinical Features of Migraine with Aura: Earlier but Not More 156
Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection - A Narrative Review 143
Cerebral vasomotor reactivity in the acute phase and after 6 months in non-disabling stroke/TIA: A prospective cohort study 142
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment 131
35. Association of robot-assisted rehabilitation and non-invasive brain stimulation to improve upper limb function in chronic stroke patients 93
Frequency and clinical implications of hypercoagulability states in a cohort of patients with migraine with aura 91
Acute medications' intake for migraine: a one-year report in patients undergoing first evaluation at a third level Italian headache center 77
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study 66
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 61
Gepants - a long way to cure: a narrative review 59
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study 57
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study 54
Calcitonin Gene-Related Peptide Systemic Effects: Embracing the Complexity of Its Biological Roles-A Narrative Review 33
May Dual Transcranial Direct Current Stimulation Enhance the Efficacy of Robot-Assisted Therapy for Promoting Upper Limb Recovery in Chronic Stroke? 20
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 6
Totale 1.864
Categoria #
all - tutte 4.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 0 0 0 0 4
2022/202312 0 0 0 0 0 0 0 0 2 1 9 0
2023/202432 3 1 3 6 3 10 0 5 0 0 0 1
2024/20251.813 2 3 7 0 2 5 37 41 53 97 770 796
2025/20263 3 0 0 0 0 0 0 0 0 0 0 0
Totale 1.864